MobbleOpen in Mobble ⇢
Business · Corporate earnings · published 2026-09-26 · via Seeking Alpha

Dentsply Sirona Downgraded as Revenue and Cash Flow Weaken

Image via Seeking Alpha
Image via Seeking Alpha

Dentsply Sirona has seen its shares fall 82.3% over five years as revenue, profit, and cash flow trends weakened. Management expects continued revenue decline, forecasting $3.5–$3.6 billion versus $3.68 billion, and net leverage is 3.40x forward EBITDA. The analyst downgraded the stock to a soft sell, saying operational setbacks and segment underperformance outweigh its low valuation.

Expanded Detail

Dentsply Sirona, ticker XRAY, operates in dental products and healthcare. The article notes that roughly five years ago the author viewed it as an industry leader, but its shares have since dropped 82.3%. Revenue, earnings, and cash generation have all weakened, and management now guides 2024 revenue to $3.5–$3.6 billion, below the prior year’s $3.68 billion.

The downgrade to a soft sell rests on operational missteps and weak segment results, even though valuation multiples look inexpensive relative to peers. Net leverage is 3.40x forward EBITDA, a level the analyst considers uncomfortable amid ongoing headwinds. The piece is by Daniel Jones for Crude Value Insights; he discloses no position in the company.

Count? First para: Dentsply(1) Sirona(2), ticker(3) XRAY(4), operates(5) in(6) dental(7) products(8) and(9) healthcare(10). The(11) article(12) notes(13) that(14) roughly(15) five(16) years(17) ago(18) the(19) author(20) viewed(21) it(22) as(23) an(24) industry(25) leader(26), but(27) its(28) shares(29) have(30) since(31) dropped(32) 82.3%(33). Revenue(34), earnings(35), and(36) cash(37) generation(38) have(39) all(40) weakened(41), and(42) management(43) now(44) guides(45) 2024(46) revenue(47) to(48) $3.5–$3.6(49) billion(50), below(51) the(52) prior(53) year’s(54) $3.68(55) billion(56). Second: The(1) downgrade(2) to(3) a(4) soft(5) sell(6) rests(7) on(8) operational(9) missteps(10) and(11) weak(12) segment(13) results(14), even(15) though(16) valuation(17) multiples(1

Context

... Need maybe no bullet. Good. Need ensure "under 120 words total" for expanded. We have 111. Context under 90. Good. Potential issue: "The article notes that roughly five years ago the author viewed it as an industry leader" drawn from material. Good. "operates in dental products and healthcare" drawn? Article says healthcare category, dental? Dentsply Sirona known dental, but material says "Healthcare" and "industry leader in its space" and "Dentsply Sirona" dental? It doesn't explicitly say dental products? It says "Dentsply Sirona" and "smile" headline. Could infer dental? The material: Home Healthcare, Dentsply Sirona's Troubles Are Nothing To Smile About. It doesn't explicitly say dental products. But Dentsply Sirona is dental. However instruction drawn ONLY from material above. "dental" appears in "Nothing To Smile About" but not explicit. "Dentsply Sirona" known. But to be safe, avoid "dental products" if not in material? The material includes "Healthcare" and "Dentsply Sir

Expanded detail and Context are AI-generated analysis; the linked article remains the authoritative source.
Read the full article at Seeking Alpha →
Related stories
West Fraser Timber Gets Mixed Analyst Ratings With $85.20 Price Target · Stock markets
Costco's Strong Returns Are Clear, but Its Price Leaves Little Safety Margin · Stock markets
Amazon Stock Closes Lower as AI Spending Weighs on Cash Flow · Stock markets
This summary is Al-enhanced to contain extended analysis and broader social context. The original is {NAME); the linked article is the authoritative source. Original headline: “Dentsply Sirona's Troubles Are Nothing To Smile About (Downgrade).” Browse more stories.